IL‐6 pathway is abnormally hyperactivated in several cancers triggering tumor cell growth and immune system inhibition. Along with genomic mutation, the IL6 pathway gene expression can be affected by DNA methylation, microRNAs, and post‐translational modifications. Computational analysis was performed on the Cancer Genome Atlas (TCGA) datasets to explore the role of IL6, IL6R, IL6ST, and IL6R transmembrane isoform expression and their epigenetic regulation in different cancer types. IL6 was significantly modulated in 70% of tumor types, revealing either up‐ or down‐regulation in an approximately equal number of tumors. Furthermore, IL6R and IL6ST were downregulated in more than 10 tumors. Interestingly, the correlation analysis demonstrated that only the IL6R expression was negatively affected by the DNA methylation within the promoter region in most tumors. Meanwhile, only the IL6ST expression was extensively modulated by miRNAs including miR‐182‐5p, which also directly targeted all three genes. In addition, IL6 upregulated miR‐181a‐3p, mirR‐214‐3p, miR‐18a‐5p, and miR‐938, which in turn inhibited the expression of IL6 receptors. Finally, the patients’ survival rate was significantly affected by analyzed targets in some tumors. Our results suggest the relevance of epigenetic regulation of IL6 signaling and pave the way for further studies to validate these findings and to assess the prognostic and therapeutic predictive value of these epigenetic markers on the clinical outcome and survival of cancer patients.

Novel insights into epigenetic regulation of il6 pathway: In silico perspective on inflammation and cancer relationship

Candido S.;Tomasello B.;Lavoro A.;Falzone L.;Gattuso G.;Libra M.
2021-01-01

Abstract

IL‐6 pathway is abnormally hyperactivated in several cancers triggering tumor cell growth and immune system inhibition. Along with genomic mutation, the IL6 pathway gene expression can be affected by DNA methylation, microRNAs, and post‐translational modifications. Computational analysis was performed on the Cancer Genome Atlas (TCGA) datasets to explore the role of IL6, IL6R, IL6ST, and IL6R transmembrane isoform expression and their epigenetic regulation in different cancer types. IL6 was significantly modulated in 70% of tumor types, revealing either up‐ or down‐regulation in an approximately equal number of tumors. Furthermore, IL6R and IL6ST were downregulated in more than 10 tumors. Interestingly, the correlation analysis demonstrated that only the IL6R expression was negatively affected by the DNA methylation within the promoter region in most tumors. Meanwhile, only the IL6ST expression was extensively modulated by miRNAs including miR‐182‐5p, which also directly targeted all three genes. In addition, IL6 upregulated miR‐181a‐3p, mirR‐214‐3p, miR‐18a‐5p, and miR‐938, which in turn inhibited the expression of IL6 receptors. Finally, the patients’ survival rate was significantly affected by analyzed targets in some tumors. Our results suggest the relevance of epigenetic regulation of IL6 signaling and pave the way for further studies to validate these findings and to assess the prognostic and therapeutic predictive value of these epigenetic markers on the clinical outcome and survival of cancer patients.
2021
Inflammation
Interleukin-6
MicroRNAs
Bioinformatics
Epigenetics
IL6
IL6R
IL6ST
Methylation
MiRNAs
TCGA
Therapeutic approaches
Tumor
DNA Methylation
File in questo prodotto:
File Dimensione Formato  
Novel Insights into Epigenetic Regulation of IL6 Pathway In Silico Perspective on Inflammation and Cancer Relationship.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Dimensione 3.28 MB
Formato Adobe PDF
3.28 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/518641
Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 29
social impact